Comprehensive gastric cancer care including adenocarcinoma, HER2-positive disease, and advanced treatment protocols for optimal outcomes.
Expert management of gastric adenocarcinoma and HER2-positive gastric cancer with FLOT, ECF regimens, targeted therapies, and comprehensive multidisciplinary care. We specialize in perioperative chemotherapy and metastatic disease management.
Upper endoscopy with biopsy, endoscopic ultrasound, and staging laparoscopy for accurate assessment.
HER2, PD-L1, MSI testing, and comprehensive genomic profiling for personalized treatment.
Lauren classification, tumor grade, lymph node assessment, and margin evaluation.
Persistent dyspepsia, heartburn, upper abdominal discomfort that doesn’t resolve with routine measures.
Feeling full quickly, poor appetite, unexplained weight loss and fatigue.
Nausea or vomiting, black tarry stools, or vomiting blood in advanced cases.
Chronic Helicobacter pylori infection increases gastric cancer risk.
High intake of smoked/salted foods, low fruits/vegetables, smoking, alcohol.
Family history, pernicious anemia, prior gastric surgery, chronic gastritis.
Regular imaging, endoscopy, and biomarker monitoring for early detection of recurrence.
Collaboration with gastric surgery, gastroenterology, and nutrition specialists.
Managing treatment side effects, nutritional support, and maintaining digestive function.